3.3. Connection of Serum IL-11 Levels, Clinical Data, and Prognosis of Ischemic Stroke Patients
All patients measured mRS scores after 90 days of treatment and divided into two groups including the mRS score ≤ 2 group and mRS score ≥ 3 group. Compared with the demographic and clinical data of two groups when the patients were hospitalized, we found no significant differences in age, sex, BMI, smoking proportion and levels of FPG, TC, and LDLC between the mRS score ≤ 2 group and mRS score ≥ 3 group (